Preferred Label : Paclitaxel/Trastuzumab Regimen;
NCIt synonyms : Paclitaxel/Trastuzumab; Paclitaxel-Trastuzumab; Paclitaxel-Trastuzumab Regimen; PH Regimen; TH Regimen; Taxol/Herceptin; Paclitaxel/Herceptin;
NCIt related terms : Paclitaxel and Trastuzumab (TH); T-H (Paclitaxel) (trastuzumab-qyyp); Paclitaxel and Trastuzumab-dkst (TH); Paclitaxel and Trastuzumab-qyyp (TH); T-H (Paclitaxel) (trastuzumab-dkst); T-H (Paclitaxel) (trastuzumab-zerc); T-H (Paclitaxel) (trastuzumab-dttb); Paclitaxel and Trastuzumab-anns (TH); T-H (Paclitaxel); Paclitaxel and Trastuzumab-zerc (TH); Paclitaxel and Trastuzumab-dttb (TH); T-H (Paclitaxel) (trastuzumab-herw); T-H (Paclitaxel) (trastuzumab-pkrb); Paclitaxel and Trastuzumab-herw (TH); T-H (Paclitaxel) (trastuzumab-anns); Paclitaxel and Trastuzumab-pkrb (TH);
NCIt definition : A regimen consisting of paclitaxel and trastuzumab that may be used in the treatment
of breast, esophageal and esophagogastric junction, and gastric cancers. Paclitaxel
weekly plus trastuzumab regimen and dose-dense paclitaxel plus trastuzumab regimen
may be used for the treatment of breast cancer.;
NCIt note : Source: NCCN Guidelines 2017;
NCI Metathesaurus CUI : CL524994;
Codes from synonyms : 5783; 129027; 128930; 128833; 129221; 129124; 136273; 136272; 129415; 136275; 136274; 129318; 136277; 136276; 136279; 136278;
Origin ID : C138051;
UMLS CUI : C4522185;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
